All together, these studies provide solid evidence that RGS6 not only suppresses TGF-β-induced EMT of NSCLC cells in vitro, but also attenuates TGF-β-promoted NSCLC metastasis in vivo. This evidence concerns the gene TGFB1 and non-small cell lung carcinoma.